What Researchers Did
Researchers conducted a systematic literature review to develop an action guide for managing vascular occlusion caused by hyaluronic acid fillers with exclusive cutaneous involvement.
What They Found
They found that pain and skin color changes are the most prevalent signs of vascular occlusion, and immediate intervention within 4-6 hours significantly improves prognosis, reversing early-stage ischemia in up to 80% of cases. High-dose hyaluronidase (1500 IU) every 15-20 minutes is the primary treatment, with ultrasound guidance potentially reducing required doses by up to tenfold.
What This Means for Canadian Patients
Patients undergoing hyaluronic acid filler treatments should be aware of the early signs of vascular occlusion, such as pain and skin color changes. Prompt recognition and immediate medical attention are crucial to prevent permanent tissue damage and improve treatment outcomes.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The study's systematic review approach relies on existing literature and specifically excluded ocular cases and older studies, which may limit its scope.